Skip to content

Alpha stage software — under active development. Data may be incomplete or change without notice.

FolioFact
FolioFact
Q2 2026 58/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Renaissance Technologies — NKTR

How Renaissance Technologies's position in Nektar Therapeutics changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Renaissance Technologies has never reported this position.

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.